Evidence 1
Activity
Activity
MIC
Antibacterial
12.5-25 µg/mL
Target
Candida albicans clinical isolates
Source & Reference
NA
Other
gainst E. coli ML35, S. aureus 502a, and C. albicans 16820. Active against drug resistant C. albicans clinical isolates (MIC 12.5-25 ug/ml) ( Basso et al., 2018 ).